These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1578927)

  • 41. Acute myelofibrosis terminating in acute lymphoblastic leukemia: case report and review of the literature.
    Dunphy CH; Kitchen S; Saravia O; Velasquez WS
    Am J Hematol; 1996 Jan; 51(1):85-9. PubMed ID: 8571944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An update of the results of intensive therapy in children with acute lymphoblastic leukemia.
    Pavlovsky S; Sackmann Muriel F; Santarelli MT; Svarch E; Jiménez E; Kohan R; Rosso A
    Leukemia; 1992; 6 Suppl 2():167-70. PubMed ID: 1578923
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma.
    Katz JA; Hvizdala E; Shuster J; Falletta JM; Schwenn M; Murphy SB
    J Clin Oncol; 1993 Oct; 11(10):2054-5. PubMed ID: 8410135
    [No Abstract]   [Full Text] [Related]  

  • 44. The childhood AML studies BFM-78 and -83: treatment results and risk factor analysis.
    Creutzig U; Ritter J; Riehm H; Budde M; Schellong G
    Haematol Blood Transfus; 1987; 30():71-5. PubMed ID: 3305225
    [No Abstract]   [Full Text] [Related]  

  • 45. Randomized multicentric Italian study on two treatment regimens for marrow relapse in childhood acute lymphoblastic leukemia.
    Rossi MR; Masera G; Zurlo MG; Amadori S; Mandelli F; Bagnulo S; Carli M; Zanesco L; Dini G; Guazzelli C
    Pediatr Hematol Oncol; 1986; 3(1):1-9. PubMed ID: 3153213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 47. Successful treatment of acute lymphoblastic leukemia in a child with cystic fibrosis.
    Gururangan S; Horner M; Rodman JH; Marina NM
    Med Pediatr Oncol; 1994; 22(6):414-6. PubMed ID: 8152404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased factor VIII activity and dural sinus thrombosis.
    Celkan T; Ozkan A; Apak H; Kuruoglu S; Yuksel L; Yildiz I
    Med Pediatr Oncol; 2002 Jul; 39(1):71-2. PubMed ID: 12116089
    [No Abstract]   [Full Text] [Related]  

  • 49. Lymphoblastic lymphoma in adults.
    Slater DE; Mertelsmann R; Koziner B; Higgins C; McKenzie S; Schauer P; Gee T; Straus D; Kempin S; Arlin Z
    J Clin Oncol; 1986 Jan; 4(1):57-67. PubMed ID: 3510283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
    Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
    Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
    [No Abstract]   [Full Text] [Related]  

  • 51. Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Attarbaschi A; Mann G; Zimmermann M; Bader P; Barisone E; Basso G; Biondi A; Cario G; Cazzaniga G; Colombini A; Flotho C; Kuhlen M; Lang P; Lauten M; Linderkamp C; Locatelli F; Lo Nigro L; Möricke A; Niggli F; Panzer-Grümayer R; Parasole R; Peters C; Caterina Putti M; Rizzari C; Suttorp M; Valsecchi MG; Conter V; Schrappe M;
    Leukemia; 2020 Jun; 34(6):1694-1700. PubMed ID: 31806872
    [No Abstract]   [Full Text] [Related]  

  • 52. Adult acute lymphoblastic leukemia: results of an aggressive regimen in India.
    Raje N; Pai S; Vaidya S; Gopal R; Parikh P; Saikia T; Pai V; Nadkarni K; Advani IM
    Leuk Lymphoma; 1994 Jul; 14(3-4):285-90. PubMed ID: 7950917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.
    González Pérez P; Serrano-Pozo A; Franco-Macías E; Montes-Latorre E; Gómez-Aranda F; Campos T
    Eur J Neurol; 2007 Jul; 14(7):826-8. PubMed ID: 17594344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin.
    Todeschini G; Tecchio C; Meneghini V; Pizzolo G; Veneri D; Zanotti R; Ricetti MM; Solero P; April F; Perona G
    Leukemia; 1998 Feb; 12(2):144-9. PubMed ID: 9519775
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.
    Thomas X; Danaïla C; Bach QK; Dufour P; Christian B; Corront B; Bosly A; Bastion Y; Gratecos N; Leblay R
    Ann Hematol; 1995 Feb; 70(2):65-9. PubMed ID: 7880925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.
    Han AR; Kim K; Jang JH; Kim WS; Ahn JS; Jung CW; Lee MH; Kang WK
    J Korean Med Sci; 2008 Apr; 23(2):278-83. PubMed ID: 18437012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ninth British Medical Research Council trial for the treatment of acute myeloid leukaemia.
    Rees JK; Gray R; Hayhoe FG
    Haematol Blood Transfus; 1987; 30():35-7. PubMed ID: 2442075
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
    Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
    Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intensive induction and early consolidation of acute lymphoid leukemia in the adult. A pilot study of feasibility and long-term development].
    Fière D; Marty M; Solal-Celigny P; Harousseau JL; Gorin NC; Desablens B; Brière J; David B; Bordessoule D; Hayat M
    Presse Med; 1989 Feb; 18(5):221-3. PubMed ID: 2522209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.